Insider · CIK 0001367451

Loewy Caroline M

Reports to the SEC for 8 companies · NEWARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001367451

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-13	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+800 sh	—	—	800
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.7K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−49.2K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−67K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2024-02-19	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+2,000 sh	—	—	2,000
2024-02-14	CEROCERO THERAPEUTICS HOLDINGS, INC.J Other	Director	JOther	+5,828 sh	—	—	5,828
2024-01-24	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,010
2023-09-09	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-05-19	PhaseBio Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+3,750 sh	—	—	3,750
2023-05-19	PhaseBio Pharmaceuticals IncRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,750 sh	—	—	0
2023-01-25	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-05-19	PhaseBio Pharmaceuticals IncRestricted Stock UnitsA Award	Director	AAward	+3,750 sh	—	—	3,750
2022-05-19	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2022-01-25	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+67K sh	—	—	67,000
2022-01-18	APTOFAptose Biosciences Inc. · Director Stock Option (Right to Buy)A Award	Former Director	AAward	+50K sh	—	—	50,000
2021-10-08	CEROCERO THERAPEUTICS HOLDINGS, INC. · Class B Common StockJ Other	Director	JOther	+17.5K sh	—	—	17,500
2021-06-03	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2021-05-27	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2021-01-26	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+32K sh	—	—	32,000
2021-01-12	eFFECTOR Therapeutics, Inc.Class B Common StockJ Other	Director	JOther	−17.5K sh	—	—	17,500
2021-01-04	APTOFAptose Biosciences Inc. · Director Stock Option (Right to Buy)A Award	Former Director	AAward	+50K sh	—	—	50,000
2020-09-21	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-03	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2020-05-15	CymaBay Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+49.2K sh	—	—	49,245
2020-03-11	APTOFAptose Biosciences Inc. · Director Option GrantA Award	Former Director	AAward	+50K sh	—	—	50,000
2020-03-11	APTOFAptose Biosciences Inc. · Director Option GrantA Award	Former Director	AAward	+50K sh	—	—	50,000
2020-01-31	APTOFAptose Biosciences Inc. · Director Option GrantA Award	Former Director	AAward	+65K sh	—	—	65,000
2019-05-09	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+9,167 sh	—	—	9,167
2019-02-27	PhaseBio Pharmaceuticals IncNon-employee Director Stock Option (right to buy)A Award	Director	AAward	+8,900 sh	—	—	8,900
2019-01-29	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+27.7K sh	—	—	27,705
2019-01-02	APTOFAptose Biosciences Inc. · Stock Options (Right to Buy)A Award	Former Director	AAward	+40K sh	—	—	40,000
2018-01-24	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2017-09-22	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2017-06-28	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-01-19	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2008-11-28	CORTCORCEPT THERAPEUTICS INC · Stock option (right to buy)A Award	Chief Financial Officer	AAward	+800K sh	$1.02	+$816K	800,000
2008-01-03	PONIARD PHARMACEUTICALS, INC.Stock OptionA Award	CFO	AAward	+60K sh	$4.18	+$251K	60,000
2007-06-14	PONIARD PHARMACEUTICALS, INC.Stock OptionA Award	CFO	AAward	+60K sh	—	—	60,000
2007-06-14	PONIARD PHARMACEUTICALS, INC.Stock OptionA Award	CFO	AAward	+35K sh	—	—	35,000
2007-06-14	PONIARD PHARMACEUTICALS, INC.Stock OptionA Award	CFO	AAward	+129K sh	—	—	128,533
2006-06-23	PONIARD PHARMACEUTICALS, INC.Stock OptionA Award	CFO	AAward	+600K sh	$1.00	+$600K	600,000

Recent filings

Accepted (ET)
Jun 134
Loewy Caroline M0000950170-24-073213
SEC(opens sec.gov)
Mar 224
Loewy Caroline M0000950170-24-035474
SEC(opens sec.gov)
Feb 214
Loewy Caroline M0001209191-24-003709
SEC(opens sec.gov)
Feb 164
Loewy Caroline M0001213900-24-015034
SEC(opens sec.gov)
Jan 264
Loewy Caroline M0001062993-24-001419
SEC(opens sec.gov)
Sep 114
Loewy Caroline M0001209191-23-049031
SEC(opens sec.gov)
May 194
Loewy Caroline M0001169245-23-000028
SEC(opens sec.gov)
Jan 274
Loewy Caroline M0001062993-23-001497
SEC(opens sec.gov)
May 204
Loewy Caroline M0001169245-22-000062
SEC(opens sec.gov)

Companies

Address

C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BLVD., SUITE 130

NEWARK, CA, 94560